Cargando…

Spezialisierte Behandlung von Darmkrebs in zertifizierten Krebszentren: Müssen Patient*innen wirklich weitere Wege auf sich nehmen?

Introduction In Germany, many cancer patients are treated outside of cancer centres certified by the German Cancer Society (DKG) resulting in underuse of these facilities and inferior oncological treatment. One way to address this issue would be to restructure the healthcare landscape by following t...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Elke, Reichebner, Christoph, Eriksen, Astrid, Hildebrandt, Meik, Kuklinski, David, Busse, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442894/
https://www.ncbi.nlm.nih.gov/pubmed/37321253
http://dx.doi.org/10.1055/a-2055-9599
_version_ 1785093700156653568
author Berger, Elke
Reichebner, Christoph
Eriksen, Astrid
Hildebrandt, Meik
Kuklinski, David
Busse, Reinhard
author_facet Berger, Elke
Reichebner, Christoph
Eriksen, Astrid
Hildebrandt, Meik
Kuklinski, David
Busse, Reinhard
author_sort Berger, Elke
collection PubMed
description Introduction In Germany, many cancer patients are treated outside of cancer centres certified by the German Cancer Society (DKG) resulting in underuse of these facilities and inferior oncological treatment. One way to address this issue would be to restructure the healthcare landscape by following the Danish approach that limits cancer treatment to specialized hospitals. Such an approach would have an impact on the travelling times to treatment centers. The present study determines the impact on patient travel times using the example of colorectal cancer. Methods For the present analysis, data from structured quality reports (sQB) and from patients insured with the AOK who underwent resection of the colon or rectum during 2018 were used. In addition, data from the DKG regarding an existing certification of a colorectal cance centre were used. Travel time was defined as the time patients spent in an average car with average traffic from the midpoint of the ZIP code of their residence to the coordinates of the hospital. The coordinates of the hospitals and the midpoints of the ZIP codes were obtained by querying the Google API. Travel times were calculated with a local Open Routing Machine server. The statistical programs R and Stata were used for analyses and cartographic representations. Results In 2018, nearly half of all patients with colon cancer were treated at the hospital nearest to their place of residence, of whom approximately 40% were treated at a certified colorectal cancer centre. Overall, only about 47% of all treatments took place at a certified colorectal cancer centre. Travel time to the chosen treatment site averaged 20 minutes. It was minimally shorter (18 minutes) if no certified centre was chosen and minimally longer (21 minutes) for those whose treatment took place in a certified colorectal cancer centre. Modeling of redistributions of all patients to certified centres resulted on an average travel time of 29 minutes. Conclusion Even if treatment were limited to specialized hospitals, treatment close to home would still be guaranteed. Regardless of certification, parallel structures can be identified, especially in metropolitan areas, which indicate a potential for restructuring.
format Online
Article
Text
id pubmed-10442894
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Georg Thieme Verlag
record_format MEDLINE/PubMed
spelling pubmed-104428942023-08-23 Spezialisierte Behandlung von Darmkrebs in zertifizierten Krebszentren: Müssen Patient*innen wirklich weitere Wege auf sich nehmen? Berger, Elke Reichebner, Christoph Eriksen, Astrid Hildebrandt, Meik Kuklinski, David Busse, Reinhard Gesundheitswesen Introduction In Germany, many cancer patients are treated outside of cancer centres certified by the German Cancer Society (DKG) resulting in underuse of these facilities and inferior oncological treatment. One way to address this issue would be to restructure the healthcare landscape by following the Danish approach that limits cancer treatment to specialized hospitals. Such an approach would have an impact on the travelling times to treatment centers. The present study determines the impact on patient travel times using the example of colorectal cancer. Methods For the present analysis, data from structured quality reports (sQB) and from patients insured with the AOK who underwent resection of the colon or rectum during 2018 were used. In addition, data from the DKG regarding an existing certification of a colorectal cance centre were used. Travel time was defined as the time patients spent in an average car with average traffic from the midpoint of the ZIP code of their residence to the coordinates of the hospital. The coordinates of the hospitals and the midpoints of the ZIP codes were obtained by querying the Google API. Travel times were calculated with a local Open Routing Machine server. The statistical programs R and Stata were used for analyses and cartographic representations. Results In 2018, nearly half of all patients with colon cancer were treated at the hospital nearest to their place of residence, of whom approximately 40% were treated at a certified colorectal cancer centre. Overall, only about 47% of all treatments took place at a certified colorectal cancer centre. Travel time to the chosen treatment site averaged 20 minutes. It was minimally shorter (18 minutes) if no certified centre was chosen and minimally longer (21 minutes) for those whose treatment took place in a certified colorectal cancer centre. Modeling of redistributions of all patients to certified centres resulted on an average travel time of 29 minutes. Conclusion Even if treatment were limited to specialized hospitals, treatment close to home would still be guaranteed. Regardless of certification, parallel structures can be identified, especially in metropolitan areas, which indicate a potential for restructuring. Georg Thieme Verlag 2023-06-15 /pmc/articles/PMC10442894/ /pubmed/37321253 http://dx.doi.org/10.1055/a-2055-9599 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Berger, Elke
Reichebner, Christoph
Eriksen, Astrid
Hildebrandt, Meik
Kuklinski, David
Busse, Reinhard
Spezialisierte Behandlung von Darmkrebs in zertifizierten Krebszentren: Müssen Patient*innen wirklich weitere Wege auf sich nehmen?
title Spezialisierte Behandlung von Darmkrebs in zertifizierten Krebszentren: Müssen Patient*innen wirklich weitere Wege auf sich nehmen?
title_full Spezialisierte Behandlung von Darmkrebs in zertifizierten Krebszentren: Müssen Patient*innen wirklich weitere Wege auf sich nehmen?
title_fullStr Spezialisierte Behandlung von Darmkrebs in zertifizierten Krebszentren: Müssen Patient*innen wirklich weitere Wege auf sich nehmen?
title_full_unstemmed Spezialisierte Behandlung von Darmkrebs in zertifizierten Krebszentren: Müssen Patient*innen wirklich weitere Wege auf sich nehmen?
title_short Spezialisierte Behandlung von Darmkrebs in zertifizierten Krebszentren: Müssen Patient*innen wirklich weitere Wege auf sich nehmen?
title_sort spezialisierte behandlung von darmkrebs in zertifizierten krebszentren: müssen patient*innen wirklich weitere wege auf sich nehmen?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442894/
https://www.ncbi.nlm.nih.gov/pubmed/37321253
http://dx.doi.org/10.1055/a-2055-9599
work_keys_str_mv AT bergerelke spezialisiertebehandlungvondarmkrebsinzertifiziertenkrebszentrenmussenpatientinnenwirklichweiterewegeaufsichnehmen
AT reichebnerchristoph spezialisiertebehandlungvondarmkrebsinzertifiziertenkrebszentrenmussenpatientinnenwirklichweiterewegeaufsichnehmen
AT eriksenastrid spezialisiertebehandlungvondarmkrebsinzertifiziertenkrebszentrenmussenpatientinnenwirklichweiterewegeaufsichnehmen
AT hildebrandtmeik spezialisiertebehandlungvondarmkrebsinzertifiziertenkrebszentrenmussenpatientinnenwirklichweiterewegeaufsichnehmen
AT kuklinskidavid spezialisiertebehandlungvondarmkrebsinzertifiziertenkrebszentrenmussenpatientinnenwirklichweiterewegeaufsichnehmen
AT bussereinhard spezialisiertebehandlungvondarmkrebsinzertifiziertenkrebszentrenmussenpatientinnenwirklichweiterewegeaufsichnehmen